Teva Pharmaceutical Industries Ltd 2012 SR
The report is Teva's first global Corporate Social Responsibility report, detailing its efforts to integrate CSR across its global operations in 2012. It highlights the company's focus on improving access to medicines, ensuring patient safety, and fostering community relations. Key environmental achievements include investing $4 million in energy efficiency projects and recycling nearly 50 percent of non-hazardous waste. The report also outlines the company's commitment to employee health, safety, and diversity, and details its first materiality assessment conducted to align strategy with stakeholder priorities.
Company: Teva Pharmaceutical Industries Ltd
Sector: Health Care
Country: Israel
Year: 2012
Type: SR
Pages: 56
Teva Pharmaceutical Industries Ltd
Corporate Social Responsibility Report
The report is Teva's first global Corporate Social Responsibility report, detailing its efforts to integrate CSR across its global operations in 2012. It highlights the company's focus on improving access to medicines, ensuring patient safety, and fostering community relations. Key environmental achievements include investing $4 million in energy efficiency projects and recycling nearly 50 percent of non-hazardous waste. The report also outlines the company's commitment to employee health, safety, and diversity, and details its first materiality assessment conducted to align strategy with stakeholder priorities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2012
Reporting Period
Jan 1, 2012 - Dec 31, 2012
Fiscal Year
2012
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees